Determination of the risk of breast and stomach cancer by identifying variants of the 5mC/T polymorphism in the intron of the KIF26B gene at position xp1: 245618129

Akishev A.G., Netesova N.A., Abdurashitov M.A., Vihlyanov I.V., Nikitin M.K., Karpov A.B., Degtyarev S.Kh.

A.G. Akishev1*, N.A.Netesova2, M.A. Abdurashitov1, I.V. Vihlyanov3, M.K. Nikitin3, A.B. Karpov4S.Kh. Degtyarev1

SibEnzyme, Novosibirsk
Epigenlab, Novosibirsk
3Altai Regional Oncology Center, 656049, Altai region, Barnaul
4Seversk Biophysical Research Centre, Seversk, Tomsk region

* corresponding author: Alexander Akishev, SibEnzyme, 2/12 Ak.Timakov Str., Novosibirsk 630117, Russia; Tel: +7 383 3334991; Fax: +7 383 3336853; E-mail: aki@sibenzyme.ru

We used GlaI/FatI-PCR assay for determination of 5mC/T polymorphism frequencies at position xp1: 245618129 (according to the GRCh38.p13 genomic assembly) in DNA preparations isolated from blood cells of 51 breast cancer (BC) patients and 63 gastric cancer patients (GC). The data obtained were compared with those previously obtained for 92 healthy blood donors.
It was shown that the cytosine in this position is predominantly is methylated in all DNA samples. The incidence of a diploid C/C set in this position in patients with breast cancer and gastric cancer is 9.8% and 7.94%, respectively. This is significantly different from the incidence of C homozygotes in healthy women (26.09%) and healthy donors of both sexes (22.83%). At the same time, the incidence of C/T heterozygotes and T/T homozygotes in patients with gastric cancer and breast cancer exceeds similar indicators for control groups of healthy people by 5.5-10.7%. Thus, the substitution of a methylated cytosine base for a thymine base at position xp1: 245618129 may be an unfavorable sign indicating a genetic predisposition to two types of oncological diseases.

Keywords: single nucleotide polymorphism 5mC/T,  human blood DNA, GlaI-PCR assay, FatI-PCR assay, breast cancer, gastric cancer

DOI: 10.26213/SE.2019.78.40307

Citation:

Akishev A.G., Netesova N.A., Abdurashitov M.A., Vihlyanov I.V., Nikitin M.K., Karpov A.B., Degtyarev S.Kh. (2021) Determination of the risk of breast and stomach cancer by identifying variants of the 5mC/T polymorphism in the intron of the KIF26B gene at position xp1: 245618129, Epigenet DNA diagnx, vol.2021(1), DOI: 10.26213/SE.2019.78.40307

This work is available at Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

Full-text-pdf

 

 

 

 

 

This article is available only on Russian

Table 1. PCR assay data for women with diagnosed breast cancer

Cq values for the cases of hydrolysis of GGCC site (HaeIII), CATG site (Fat-PCR assay) and  A(5mC)GC site (GlaI-PCR assay) and difference between Cq values of last two reactions with the first one (ΔCq_T = ΔCq_CATG – ΔCq_GGCC and  ΔCq_5mC = ΔCq_A(5mC)GC – ΔCq_GGCC).

Samle

Age

I

Cq_GGCC

II

Cq_CATG

III

Cq_A(5mC)GC

ΔCq_T

(II – I)

ΔCq_5mC

(III-I)

BC57

54

21.82±0.061

22.57±0.208

22.6±0.03

0.78

0.75

BC58

59

21.79±0.153

21.77±0.149

29.35±0.578

7.56

-0.02

BC59

62

22.16±0.055

25.34±0.094

22.12±0.084

-0.04

3.18

BC60

60

23.22±0.093

23.39±0.228

28.98±0.139

5.76

0.17

BC67

36

21.56±0.158

22.33±0.205

22.34±0.094

0.78

0.77

BC72

65

22.41±0.134

23.22±0.173

23.39±0.204

0.98

0.81

BC107

50

22.99±0.155

22.86±0.048

31.59±0.487

8.6

-0.13

BC117

65

21.69±0.024

21.66±0.032

27.97±0.123

6.28

-0.03

BC190

70

21.99±0.023

22±0.138

29.61±0.522

7.62

0.01

BC191

62

20.58±0.051

21.49±0.051

21.53±0.025

0.95

0.91

BC192

66

21.57±0.089

21.59±0.081

29.17±0.511

7.6

0.02

BC193

69

21.75±0.121

21.86±0.153

28.45±0.085

6.7

0.11

BC194

65

21.31±0.083

22.12±0.183

22.28±0.099

0.97

0.81

BC196

73

22.31±0.041

24.59±0.089

22.21±0.023

-0.1

2.28

BC197

65

21.55±0.106

22.56±0.109

22.54±0.121

0.99

1.01

BC198

58

21.18±0.215

21.96±0.169

22.29±0.098

1.11

0.78

BC199

58

21.46±0.121

21.49±0.078

29.71±0.376

8.25

0.03

BC201

65

21.62±0.064

21.48±0.087

28.81±0.388

7.19

-0.14

BC202

50

21.68±0.09

21.68±0.143

30.19±0.81

8.51

0

BC203

78

22.24±0.115

22.3±0.074

30.8±0.582

8.56

0.06

BC204

31

21.67±0.062

22.5±0.067

22.75±0.036

1.08

0.83

BC206

50

21.4±0.125

22.23±0.165

22.25±0.137

0.85

0.83

BC207

63

21.52±0.096

21.4±0.071

29.69±0.518

8.17

-0.12

BC208

67

21.6±0.047

22.46±0.043

22.58±0.053

0.98

0.86

BC292

62

21.98±0.207

23.02±0.005

23.17±0.064

1.19

1.04

BC293

62

22.35±0.105

22.32±0.007

28.77±0.292

6.42

-0.03

BC294

71

22.12±0.028

23.1±0.106

23.16±0.098

1.04

0.98

BC295

62

22.32±0.036

22.11±0.222

30.97±0.64

8.65

-0.21

BC296

58

21.3±0.068

22.04±0.024

22.13±0.093

0.83

0.74

BC297

70

20.7±0.092

20.57±0.051

28.56±0.617

7.86

-0.13

BC298

58

21.54±0.103

21.4±0.098

28.92±0.289

7.38

-0.14

BC299

64

21.71±0.021

21.55±0.048

30.02±0.263

8.31

-0.16

BC300

66

22.1±0.126

23.11±0.054

22.95±0.028

0.85

1.01

BC301

44

21.63±0.18

22.44±0.113

22.74±0.125

1.11

0.81

BC302

63

21.71±0.089

22.68±0.196

22.84±0.04

1.13

0.97

BC303

58

21.71±0.113

25.06±0.103

21.57±0.066

-0.14

3.35

BC304

41

21±0.069

21.58±0.117

21.85±0.196

0.85

0.58

BC320

50

23.24±0.045

24.24±0.148

24.28±0.084

1.04

1

BC321

48

23.22±0.04

23.09±0.082

29.61±0.692

6.39

-0.13

BC322

48

21.59±0.203

22.45±0.188

22.46±0.166

0.87

0.86

BC323

63

22.44±0.086

22.28±0.037

28.35±0.173

5.91

-0.16

BC324

63

22.3±0.092

23.06±0.035

23.4±0.098

1.1

0.76

BC325

42

21.39±0.109

22.3±0.021

22.27±0.056

0.88

0.91

BC326

69

22.11±0.019

22.18±0.167

28.66±0.383

6.55

0.07

BC327

62

22.67±0.096

25.64±0.096

22.44±0.09

-0.23

2.97

BC328

44

22.38±0.052

22.28±0.075

29.05±1.272

6.67

-0.1

BC329

61

22.17±0.079

23.03±0.048

23.06±0.013

0.89

0.86

BC330

71

22.06±0.066

22.69±0.119

22.99±0.108

0.93

0.63

BC331

67

21.63±0.118

22.48±0.048

22.58±0.046

0.95

0.85

BC332

63

21.29±0.162

22.09±0.193

22.34±0.091

1.05

0.8

BC333

66

21.32±0.075

24.66±0.041

21.1±0.158

-0.22

3.34

Table 2. PCR assay data for patients with diagnosed gastric cancer

All collumns as in Table 1.

Sample

Age

Sex

I

Cq_GGCC

II

Cq_CATG

III

Cq_A(5mC)GC

ΔCq_T

(II – I)

ΔCq_5mC

(III-I)

GC38

60

f

20.71±0.139

21.49±0.191

21.56±0.056

0.78

0.85

GC41

47

f

22.08±0.102

27.23±0.25

21.93±0.193

5.15

-0.15

GC43

59

m

22.24±0.071

23.31±0.023

23.02±0.055

1.07

0.78

GC45

51

m

22.72±0.142

32.35±1.843

22.5±0.092

9.63

-0.22

GC47

62

m

20.37±0.086

21.38±0.07

21.37±0.1

1.01

1

GC49

46

m

21.28±0.081

28.17±0.139

21.38±0.068

6.89

0.1

GC50

53

m

22.11±0.146

23.09±0.051

23.02±0.15

0.98

0.91

GC51

77

m

21.1±0.133

28.24±0.361

20.96±0.056

7.14

-0.14

GC54

70

f

20.62±0.057

21.85±0.07

21.54±0.133

1.23

0.92

GC80

72

m

22.58±0.091

23.58±0.07

23.79±0.142

1

1.21

GC98

52

m

21.33±0.068

22.23±0.077

22.16±0.013

0.9

0.83

GC99

56

m

24.62±0.142

25.84±0.077

25.48±0.097

1.22

0.86

GC132

75

f

21.08±0.028

28.96±0.596

20.92±0.152

7.88

-0.16

GC133

72

f

21.88±0.141

22.94±0.076

22.69±0.168

1.06

0.81

GC146

80

m

22.84±0.118

23.63±0.058

23.73±0.084

0.79

0.89

GC148

61

m

21.27±0.06

28.37±0.325

21.37±0.165

7.1

0.1

GC149

83

m

20.79±0.05

28.11±0.132

20.6±0.098

7.32

-0.19

GC150

57

m

21.37±0.024

27.21±0.589

21.35±0.073

5.84

-0.02

GC151

50

m

20.22±0.115

21.17±0.06

21.06±0.126

0.95

0.84

GC154

61

m

20.95±0.05

22.07±0.05

21.9±0.218

1.12

0.95

GC156

70

m

20.59±0.132

27.34±0.126

20.59±0.043

6.75

0

GC157

37

m

21.91±0.144

23.1±0.116

22.87±0.124

1.19

0.96

GC 158

76

f

22.16±0.044

30.49±1.099

22.17±0.177

8.33

0.01

GC161

49

m

20.85±0.185

21.85±0.04

21.76±0.069

1

0.91

GC182

54

m

20.21±0.054

21.31±0.036

21.26±0.116

1.1

1.05

GC184

69

m

21.16±0.058

30.1±0.264

21.13±0.111

8.94

-0.03

GC185

69

m

21.42±156

29.14±1.04

21.48±82

7.72

0.06

GC186

59

f

21.19±0.029

21.95±0.181

22.07±0.165

0.88

0.76

GC187

70

f

21.06±0.044

22.02±0.108

21.91±0.181

0.96

0.85

GC209

59

f

21.06±0.02

21.82±0.163

22.05±0.175

0.99

0.76

GC211

65

f

21.53±0.13

30.17±0.719

21.41±0.07

8.64

-0.12

GC214

82

f

21.71±0.064

28.38±0.625

21.79±0.059

6.67

0.08

GC215

81

f

21.34±0.086

22.22±0.026

22.22±0.128

0.88

0.88

GC220

48

m

20.58±0.043

21.49±0.007

21.76±0.163

0.91

1.18

GC224

57

m

21.57±0.136

29.9±0.476

21.48±0.148

8.33

-0.09

GC225

72

f

21.59±0.096

29.69±0.964

21.58±0.162

8.1

-0.01

GC227

79

m

21.5±0.081

29.63±0.38

21.47±0.089

8.13

-0.03

GC 230

63

f

21.73±0.121

22.73±0.125

22.57±0.125

1

0.84

GC 232

64

f

22.39±0.084

22.36±0.092

25.09±0.033

-0.03

2.7

GC 233

62

f

21.17±0.048

22.17±0.064

21.93±0.077

1

0.76

GC 234

61

m

21.21±0.039

22.13±0.047

22.15±0.107

0.94

0.92

GC243

75л

m

23.07±0.047

24.04±0.007

23.87±0.195

0.97

0.8

GC250

67

m

22.73±0.163

29.5±0.41

22.56±0.049

6.77

-0.17

GC276

35

f

21.23±0.058

26.34±0.982

21.29±0.107

5.11

0.06

GC277

72

f

21.34±0.09

21.36±0.025

24.08±0.11

0.02

2.74

GC280

67

m

22.34±0.122

23.4±0.031

23.11±0.069

1.06

0.77

GC282

68

f

21.42±0.092

22.44±0.122

22.31±0.064

1.02

0.89

GC284

46

m

22.56±0.065

23.74±0.186

23.35±0.076

1.18

0.79

GC285

71

f

21.56±0.054

30.42±0.812

21.42±0.118

8.86

-0.14

GC286

66

m

21.28±0.112

21.42±0.064

24.01±0.103

0.14

2.73

GC287

63

m

21.17±0.128

22.18±0.072

22.06±0.023

1.01

0.89

GC315

74

f

21.54±0.071

22.36±0.116

22.36±0.125

0.82

0.82

GC316

67

m

20.54±0.146

21.75±0.049

21.38±0.075

1.21

0.84

GC 317

74

m

21.62±0.037

28.98±0.159

21.47±0.022

7.36

-0.15

GC 318

71

m

22.39±0.041

23.62±0.127

23.26±0.05

1.23

0.87

GC319

57

m

21.51±0.046

29.65±0.212

21.64±0.139

8.14

0.13

GC334

67

f

20.44±0.025

21.36±0.025

21.29±0.044

0.92

0.85

GC335

55

f

21.52±0.025

21.35±0.2

24.21±0.035

-0.17

2.69

GC340

65

m

22.21±0.018

22.13±0.129

24.2±0.176

-0.08

1.99

GC341

74

f

22.45±0.08

23.29±0.135

23.34±0.09

0.84

0.89

GC342

72

m

22.38±0.073

30.24±0.368

22.27±0.139

7.86

-0.11

GC343

72

m

21.58±0.107

22.35±0.022

22.43±0.066

0.85

0.77

GC344

62

m

22.23±0.085

30.9±1.269

22.27±0.107

8.67

0.04

Table 3.

Distribution of diploid sets of alleles in position xp1: 245618129 in healthy people and patients with breast cancer and gastric cancer. The percentage values of the sample size are given; the number of people with a given diploid set is indicated in parentheses.

Diploid sets Healthy donors (46 ,

women)

Breast cancer(51) Healthy donors (92,

both sexes)

Gastric cancer (63)
C/C 26.09 (12) 9.8 (5) 22.83 (21) 7.94 (5)
C/T 43.48 (20) 49 (25) 46.74 (43) 53.97 (34)
T/T 30.43 (14) 41.2 (21) 30.43 (28) 38.1 (24)

Picture 1

Comparison of the percentage of diploid sets of alleles in position xp1: 245618129 in healthy donors and patients with breast cancer (top) and breast cancer (bottom).

Print Friendly, PDF & Email

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More